Table 1.

The effect of decitabine induction on human erythroid progenitor cell cultures. The effect of decitabine on the levels of fetal hemoglobin levels in primary human erythroid progenitor cells from healthy and thalassemic donors. Fetal hemoglobin (HbF) levels were determined after 6 days of treatment with decitabine (Dec). The results are the average of 12 healthy cultures and 11 thalassemic cultures.

Samples	HbF Levels (% Relative to Un-Treated Control)	p-Value (Paired t-Test ± Dec)
Healthy	62.68 ± 28.66	0.00003
Thalassemic	43.89 ± 38.72	0.0027